NCT00094120终止2 期
Safety and Efficacy of MSI-1256F (Squalamine Lactate) in Combination With Verteporfin in Patients With "Wet" Age-Related Macular Degeneration (AMD)
Genaera Corporation1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2004年10月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 终止
- 发起方
- 入组人数
- 60
- 试验地点
- 1
研究概览
简要总结
Age-Related Macular Degeneration (AMD) is a degenerative disease of the retina that causes a progressive loss of central vision. AMD is the leading cause of legal blindness among adults age 50 or older in the Western world. AMD presents in two different types - "dry" and the more severe "wet" form. Wet AMD is caused by the growth of abnormal blood vessels in the macula.
Squalamine lactate is an investigational drug that may prevent the growth of these abnormal blood vessels. This study will test the safety and efficacy of Squalamine when administered with verteporfin therapy in patients with "wet" AMD.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 50 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with a diagnosis of "wet" age-related macular degeneration
排除标准
- •Prior treatment for "wet" age-related macular degeneration
研究者
研究点 (1)
Loading locations...
相似试验
终止
2 期
A Safety and Efficacy Study of MSI-1256F (Squalamine Lactate) To Treat "Wet" Age-Related Macular DegenerationMacular DegenerationNCT00089830Genaera Corporation120
终止
2 期
A Study of MSI-1256F (Squalamine Lactate) To Treat "Wet" Age-Related Macular DegenerationMacular DegenerationNCT00333476Genaera Corporation140
已完成
1 期
A Study to Test Different Doses of BI 836880 in Patients With an Eye Disease Called Wet Age-related Macular Degeneration (wAMD)Wet Macular DegenerationNCT03861234Boehringer Ingelheim43
招募中
1 期
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular DegenerationAge-Related Macular DegenerationNCT03178149Astellas Institute for Regenerative Medicine42
暂停
3 期
Safety and Effectiveness Investigation for Dry, Non-Exudative Age Related Macular Degeneration (AMD) Using RheopheresisAge-Related MaculopathyNCT00460967OccuLogix325